Are you Dr. Hsia?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 69 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce St
8 Penn Tower
Philadelphia, PA 19104Phone+1 215-662-2415- Is this information wrong?
Summary
- Dr. Elizabeth Hsia, MD is a rheumatologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania. She is affiliated with Hospital of the University of Pennsylvania and is an Adjunct Assistant Professor of Medicine at Penn Medicine.
Education & Training
- University of Pennsylvania Health SystemFellowship, Rheumatology, 1998 - 2002
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 1998
- Yale School of MedicineClass of 1996
Certifications & Licensure
- PA State Medical License 1997 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 9 citationsCollagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).Georg Schett, Matthew J Loza, Arumugam Palanichamy, Oliver FitzGerald, Christopher Ritchlin, Anne-Christine Bay-Jensen, Signe Holm Nielsen, Sheng Gao, Elizabeth C Hsia...> ;Rheumatology and Therapy. 2022 Aug 1
- 1 citationsPublisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DIS...Georg Schett, Matthew J Loza, Arumugam Palanichamy, Oliver FitzGerald, Christopher Ritchlin, Anne-Christine Bay-Jensen, Signe Holm Nielsen, Sheng Gao, Elizabeth C Hsia...> ;Rheumatology and Therapy. 2022 Aug 1
- 38 citationsLong-term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through 2 Years: Results from a Phase 3, Randomized, ...Iain B. McInnes, Proton Rahman, Alice B. Gottlieb, Elizabeth C. Hsia, A. Kollmeier, Xie L. Xu, Y. Jiang, S. Sheng, M. Shawi, Soumya D. Chakravarty, Désirée van der Hei...> ;Arthritis & Rheumatology. 2021 Nov 1
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania